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Background/aim: Nonalcoholic fatty liver is one of the most common forms of liver disease and role of microRNAs (miRNAs) on this
illness is currently unclear. It was aimed to evaluate the predictive role of circulating miR-33a and mir-200c on high fructose corn syrup
(HFCS)-induced fatty liver and vitamin D3 supplementation-related hepatic changes.
Materials and methods: Twenty-four rats were randomized into three groups: sham (n = 8), experimental fatty liver group (n = 8), and
fatty liver + vitamin D3 supplementation group (n = 8). In the treatment group, 10 µg/kg/week of vitamin D3 was given by orogastric tube
weekly for 4 weeks in addition to a high fructose diet. Serum AST, ALT, TNF-α, and MDA levels were tested. Liver tissue samples were
examined using hematoxylin/eosin, periodic acid-Schif (PAS) and Masson’s Trichrome staining. Circulating miR-33a and mir-200c
were quantified by qRT-PCR method. Moreover, in silico analyses were accomplished.
Results: In the vitamin D3 group, results of biochemical parameters were significantly different than those of the fatty liver group (p
< 0.001). Moreover, significant differences in serum levels of circulating miR-33a and mir-200c were identified among all groups (p <
0.05). Finally, more favorable histopathological changes were noticed in the vitamin D3 supplementation group. The expressions of Ki67 were also considerably reduced in the vitamin D3 group. According to KEGG pathway analysis, mir-33a and mir-200c were found to
play a common role in the Hippo signaling pathway, lysine degradation, and protein processing.
Conclusion: Our current experimental fatty liver study showed that, in a specified dose, vitamin D3 supplementation could alleviate
adverse undesirable hepatic effects of HFCS via miR-33a and mir-200c.
Key words: Fatty liver, vitamin D3, microRNA, biomarker, rat

1. Introduction
Metabolic syndrome, obesity, and fatty liver prevalence
have increased in the last few decades all over the world.
The lack of physical activity and modern western-style
diet are the two major factors for this epidemic [1, 2].
A major component of this epidemic, nonalcoholic
fatty liver disease (NAFLD) is defined as more than 5%
triglyceride accumulation in the liver that can lead to
steatosis and increased inflammation in some cases,

resulting in nonalcoholic steatohepatitis in (NASH) and
eventually in cirrhosis and hepatocellular carcinoma [13]. Dietary factors have been postulated as having roles in
development of hepatic steatosis; however, these factors
should be investigated in a detailed manner in order to
develop curative therapeutic options [2,3]. In addition
to the individual differences, the variability in the eating
habits and weighted food products resulting from ethnic
and cultural variation may determine these consequences
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[4]. As a feature of modern western-style diet, the increase
in the consumption of high-fructose corn syrup (HFCS)
and other corn products is currently under debate in terms
of its association with epidemic of NAFLD [5].
Currently, vitamin D deficiency is common in Western
countries, particularly in the northern residential areas.
The prevalence of vitamin D deficiency is about 40%,
ranging from 15% and 80% in previous studies [6, 7]. This
variation is mainly determined by the racial differences.
Interestingly, even in people living in sunny countries in the
Mediterranean region, vitamin D deficiency is sometimes
more common than that seen in northern European
countries [6, 7] . In addition, in recent studies, vitamin D
deficiency is not only associated with calcium-phosphorus
metabolism but also is associated with the metabolic
syndrome, insulin resistance, and NAFLD. Moreover,
determining the efficacy of vitamin D supplementation on
fatty liver tissue is still an important research topic [8, 9].
MicroRNAs are short noncoding RNA sequences of
approximately 18–22 nucleotides in length that regulate
gene expression [10]. The presence of some deregulated
miRNAs in NAFLD has been reported and most of them are
known to be effective in lipid and cholesterol metabolism.
In addition, many miRNAs have been shown to regulate
insulin resistance, oxidative stress, and inflammation [11],
which are considered critical components of NAFLD.
miRNAs act as posttranscriptional regulators and again
miRNAs can target hundreds of different genes. In addition,
genes can be targeted by many different miRNAs. In recent
years, it has been suggested that various miRNAs may have
oxidative stress, apoptosis, and endoplasmic reticulum
regulatory effects in liver tissue. It has been scientifically
proven that miRNAs perform many important functions
in various physiological and pathological processes
occurring in the liver [10-11]. There is insufficient
information about effects of vitamin D3 supplementation
on fibrogenic miRNAs that play a role in fatty liver. On the
other hand, modulatory role of vitamin D3 on miRNAs are
another important topic of investigation [12].
It has been reported that mir-200c may contribute
to hepatic lipid metabolism. In addition, its expression
levels are associated with hepatic steatosis and hepatic
inflammation [13] . On the other hand, it has been
postulated that mir-33a is dysregulated in high-fat-dietinduced fatty liver disease and affect disease course [14].
However, there is no study examining the relationship
between vitamin D3 supplementation and these two
circulating miRNAs in HFCS induced fatty liver model.
Moreover, investigating these two circulating miRNAs
as candidate biomarker for predicting NAFLD and also
fatty liver treatment success is an inevitable concern.
In this study, it was aimed to evaluate the predictive role
of circulating miR-33a and mir-200c on HFCS-induced

fatty liver and vitamin D3 supplementation-related liver
biochemical and histopathological changes.
2. Materials and methods
2.1. Characteristics of animals
In this study, 24 male Sprague–Dawley albino rats at 8
weeks, weighing 200–220 g, were used. Animals were fed
ad libitum and housed in steel cages having a temperaturecontrolled environment (22 ± 2 °C) with 12-h light/dark
cycles. The sample size was calculated as a minimum of 5
rats per group with Type 1 error α = 0.05 and study power
1-β = %80 using MedCalc® Statistical Software (MedCalc
Software Ltd, Ostend, Belgium). All experimental
procedures were ethically approved by the University of
Health Sciences, Hamidiye Animal Experiments Local
Ethics Committee, Turkey. Moreover, National Guide for
the Care and Used of Laboratory Animal Experiment
Guidelines was followed.
2.2. Experimental protocol
2.2.a. Beginning
The study was started when the animals were 8 weeks old
(day 0 of the study).
2.2.b. First 8 weeks
Rats were divided into two groups. The first group included
8 rats and was called sham (healthy control) group. This
group was given a normal diet. There were 16 rats in the
other group and the animals in this group were fed with
HFCS.
2.2.c. 8–12 weeks
The first group, in other words the healthy control group,
continued to be fed with a normal diet (Group 1). Rats
in the experimental fatty liver group were divided into 2
groups. One of them included 8 rats. In this group (Group
2), in addition to the HFCS, rats were given drinking water
with an orogastric tube (equal to the amount of vitamin
D3 replacement with orogastric tube in the next group)
weekly for 4 weeks. The last group (Group 3) included 8
rats. They were fed with HFCS, and they were also given 10
µg/kg/week of vitamin D3 (Devit, DEVA, Kocaeli, Turkey)
by orogastric tube weekly for 4 weeks. In order to induce
experimental fatty liver disease model, 35% HFCS was
added to drinking water.
At the end of the 12th week, all animals were
anesthetized by intraperitoneal (ip) injection of ketamine
(40 mg/kg) and xylazine (4 mg/kg) for sacrifice, then
intracardiac blood samples were taken, laparotomy was
accomplished, and liver tissues were obtained.
2.3. Biochemical analysis
The blood samples were obtained after the sacrifice
procedure, centrifuged at 4000 rpm for 15 min at room
temperature and the serums were separated. All blood
samples were stored at –80 °C until the biochemical
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analysis. Tumor necrosis factor (TNF)-alpha, aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
and malondialdehyde (MDA) levels were measured
with an ELISA device (BioTek Epoch 2 Microplate
Spectrophotometer and ELx50 Microplate Strip Washer,
Santa Clara, USA) using enzyme-linked immune sorbent
measurement (ELISA) kits (Fine Test, Wuhan Fine Biotech
Co., Wuhan, Hubei, China). All measurements were made
following the instructions included in the study kits.
2.4. Histopathological evaluation
2.4.a. Light microscopic study
For histochemical and immunohistochemical studies,
rat liver tissue samples were perfused with 200 mL of 4%
formaldehyde in 0.1 M phosphate-buffer saline (PBS).
After routine procedures, 5-µm-thick liver tissue sections
were obtained from formalin-fixed paraffin-embedded
tissues with Leica-RM2145 microtome (Nussloch,
Germany). All of the stained sections were photographed
with Olympus DP72 digital camera mounted on Olympus
BX51 microscope (Tokyo, Japan). Slides chosen at random
were performed blind microscopic analysis by three
histologists at different times/noncontemporary.
2.4.b. Histochemical evaluation
Liver tissue sections were stained with Hematoxylin and
Eosin (H&E) (Dako, Glostrup, Denmark) as routine;
periodic acid-Schif (PAS) (bio-Optica, Milano, Italy)
and Mallory Trichrome (bio-Optica, Milano, Italy)
as recommended by the manufacturer’s instructions.
Liver damage was examined including the criteria
of macrovesicular steatosis, microvesicular steatosis,
hepatocyte hypertrophy, and inflammation based on the
study by Liang et al. [15]. Briefly macrovesicular steatosis,
microvesicular steatosis and hepatocyte hypertrophy
criteria were grouped as steatosis meanwhile steatosis and
inflammation were evaluated together within NAFLD
scoring system for rodents listed in Table 1. One from each
block at random, a total of 8 H&E stained sections from
each group were selected. Five randomly selected areas
were scored as a percentage over 40× (total magnification

400×) magnification. The “percentage of the total area
affected” value was obtained by taking the average of these
percentage scores recorded at different times by 3 different
observers. The severity of adiposity was determined by
performing histological steatosis staging (Grade 0-1-23) over these percentage values obtained by dividing the
whole area (Table 1).
2.4.c. Immunohistochemistry protocol
For immunohistochemistry, sections were incubated with
H2O2 (10%) for 30 min to eliminate endogenous peroxidase
activity and blocked with 10% normal goat serum for 1 h at
room temperature. Subsequently, sections were incubated
in primary antibodies, Ki-67 (Bioss, Inc., Massachusetts,
USA, 1/100), iNOS (Santa Cruz Biotechnology, Inc.,
Texas, USA, 1/100) for 24 h at 4 °C. Antibody detection
was performed with the Histostain-Plus Bulk kit (Bioss,
Inc., Massachusetts, USA) against rabbit IgG, and 3,3’
diaminobenzidine (DAB) was used to visualize the
final product. All sections were washed in PBS and
photographed. The slides used in immunohistochemical
evaluation were selected at random by three blind
observers. Observers examined Ki-67 and iNOS stained
slides, eight per both, from each experimental group. One
hundred cells were counted at 40× magnification (total
magnification 400×). The number of cells that reacted
positively was noted, while the latter score was obtained by
taking the average. Based on this, immunohistochemical
positivity was evaluated as follows: Score 0 (–): 0–5 cells
with positive reactions, Score 1 (+): 5–15 cells with positive
reactions, Score 2 (++): 15–25 cells with positive reactions,
Score 3 (++): 26 and more cells with positive reactions.
2.5. RNA extraction from serum samples
The miRNeasy serum/plasma kit (QIAGEN, Hilden,
Germany) was used to perform RNA isolation. Two
hundred microliters of serum were mixed by vortexing
with 1 mL of QIAzol Lysis Reagent. After incubation at
room temperature for 5 min, 200 μL of chloroform was
added to the homogenized sample, vigorously vortexed,
and incubated at room temperature for 3 min. After
centrifugation at 12000 × g at 4 °C for 15 min, upper

Table 1. Histological scoring system for NAFLD.
Score
0

Score
1

Score
2

Score
3

Macrovesicular steatosis

<5%

5%–33%

33%–66%

> 66%

Microvesicular steatosis

<5%

5%–33%

33%–66%

> 66%

Hepatocellular hypertrophy

<5%

5%–33%

33%–66%

> 66%

<0.5

0.5–1

1–2

>2

Histological feature
Steatosis

Inflammation
Number of inflammatory foci/field
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aqueous phase were taken to a new collection tube and
100% ethanol was added. Samples were then transferred
to RNeasy MinElute spin column. RNA was precipitated
with 750 μL of ethanol, triple washed with RPE-buffer,
followed by RNA-elution in 20 μL of nuclease-free water,
and storage at −80 °C.
2.6. Quantitative RT-PCR
Quantitative RT-PCR was performed for the analysis of
miRNA expression. cDNA was synthesized using the
Taqman miRNA Reverse Transcription Kit (Thermo
Fisher, MA, USA). It was then PCR-amplified using
Taqman Master Mix (Thermo Fisher, MA, USA). RNU6B
was used internally. miRNA levels were quantified by
Roche Real-Time 480 PCR (Roche, CA, USA). Relative
mRNA expression levels were calculated by the 2 − ΔΔCt
method.
2.7. Statistical analysis
InStat3 GraphPad Statistics Software (trial version) and
IBM SPSS Statistics 18 software were utilized for all tests.
Visual (histogram and probability graphs) and analytical
methods were used for predicting normal distribution.
Normally distributed data in this study were expressed
as mean ± SD. Analysis of variance (ANOVA) was used
for multiple group comparisons. Those with p-values of
<0.05 were considered statistically significant. When a
significant difference was noticed between study groups,
post hoc tests were performed. qRT-PCR results were
analyzed with one way ANOVA test.
3. Results
3.1. Biochemical results
After one-way ANOVA with Bonferroni post hoc test was
performed on biochemical results, statistically significant
differences were detected. When the research groups
were examined in terms of AST and ALT levels, there
were significant differences between the HFCS-induced
fatty liver group and vitamin D3 supplementation group

(p < 0.001). Moreover, there was a significant difference
in serum MDA levels between the fatty liver group and
vitamin D3 group (p < 0.01). On the other hand, there
was a statistically significant difference in serum TNFalpha levels between the experimental NAFLD group and
vitamin D3 groups (p < 0.01) (Table 2).
3.2. Histopathological examination results
In examination of Group 1 slides, stained with H&E,
Mallory Trichrome and PAS, normal
appearances of the histological structure of liver tissues
were observed (Figures 1a–1c). General histological
observations consisted of vena centralis located at the
center of classical liver lobe, hepatocytes with centralsettled nucleus and eosinophilic cytoplasm, neatly lined
remark cords around vena centralis and portal areas, and
regular sinusoidal structures. Mallory trichrome staining
showed no increase in connective tissue. Glucogen
distribution among the hepatocytes with PAS staining
was normal. No obvious infiltration of inflammatory
cells, fibrosis or necrosis was observed, with the exception
of minor hepatic steatosis. Liver lobules of experimental
fatty liver group were disordered. Dispersed remark
cords, sinusoidal dilation, inflammatory cell infiltration,
hypertrophic hepatocytes filled with multiple fat droplets
with central nuclei (microvesicular hepatic steatosis) and
hepatocytes filled with large fat droplet with peripheral
nuclei (macrovesicular hepatic steatosis) were detected
in liver sections of fatty liver group (Figures 1d–1f).
NAFLD scores were significantly higher in Group 2 rats.
No significant connective tissue increase or fibrosis was
observed with stained Mallory Trichrome sections in
Group 1. Hepatocytes of Group 2 rats were stained by
PAS, which indicated the presence of glycogen around the
central vein and portal area. Liver architecture integrity of
the vitamin D3 group (Group 3) was partially protected
(Figure 1g–1i). A dispersed distribution of hepatocytes
with fewer lipid droplets per cell was observed in Group
3. Moreover, microvesicular steatosis and hepatocellular

Table 2. Biochemical analysis results according to groups.
Sham

Fatty liver

Vitamin D3

p-values

n

8

8

8

-

TNF-α, pg/mL

40.1 ± 6.3

53.8 ± 6

44.6 ± 4.9

a

ALT, IU/L

50.8 ± 6.4

101.3 ± 11.3

64 ± 9

a

AST, IU/L

57 ± 5.5

116 ± 13.4

69.6 ± 8.8

a

MDA, ng/mL

26.3 ± 4.8

38.2 ± 6.9

29.6 ± 4.7

a

0.01
0.001
0.001
0.01

a One-way ANOVA test with post hoc test (Bonferronni Test). Results are expressed as mean ± standard deviation (SD).
TNF-α: Tumor necrosis factor alpha, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, MDA: Malondialdehyde.
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Figure 1. a–c. Normal liver morphology with central vein, wellorganized sinusoids and remark cords. Hepatocytes revealed
normal cell shape with centrally placed nucleus and eosinophilic
cytoplasm. Normal Kupffer cells. No increase in the connective tissue.
Homogeneous staining of normal glycogen distribution.
d–f. Disorganized liver architecture. Dilated sinusoids, dispersed
remark cords and inflammatory cells infiltration were detected.
Fatty degenerations as microvesicular steatosis in the hypertrophic
hepatocytes with granular cytoplasm and Kupffer cells are indicated.
No significant increase in the connective tissue was confirmed.
Presence of glycogen deposition was confirmed by strong positive
PAS reaction.
g–i. Partially protected liver architecture. Reduced microvesicular
steatosis, and hepatocellular hypertrophy. Pronounced inflammatory
cells infiltration. Mild activation of Kupffer cells. Scale bar = 20 µm,
total magnification 400×. CV: central vein, S: sinusoids, R: remark
cords, H: hepatocytes, arrow: Kupffer cells, arrowhead: microvesicular
steatosis, asterisk: hepatocellular hypertrophy, star: inflammatory foci.

Table 3. Histological scores of rat groups.
Histological feature

Group 1

Group 2

Group 3

Steatosis

Score

Score

Score

● Macrovesicular steatosis

0

1

1

● Microvesicular steatosis

0

2

1

0

2

1

Inflammation

Score

Score

Score

● Number of inflammatory foci/field

0

2

2

● Hepatocellular hypertrophy

hypertrophy were reduced in Group 3. In addition, NAFLD
scores were considerably reduced in Group 3 compared to
Group 2. On the other hand, pronounced inflammatory
cell infiltration and mild activation of Kupffer cells were
observed around hepatocytes and portal area. In the
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vitamin D3 supplementation group, the distribution of
PAS stained cells was closer to that of the control (Table 3).
3.3. Immunohistochemistry results
In the sham group, liver sections showed negative
immunochemical reaction of Ki-67 (Figures 2A and 2B).

TANOĞLU et al. / Turk J Med Sci
Liver specimens of Group 2 exhibited strong positive
expression of Ki-67 (Figures 2C and 2D). The expression
of Ki-67 was considerably reduced in Group 3 compared
to Group 2 (Figures 2D and 2E). The expressions of iNOS
were hardly detected in the control group. In contrast,
it was increased significantly in Group 2 and iNOS
immunoreactivity was observed around central vein and
in cytoplasm of hepatocytes. We observed that iNOS
expression in Group 3 is similar to that in Group 2 (Figure
3) (Table 4).
3.4. Quantitative RT-PCR and in silico analyses results
After the real-time PCR procedure, miR-33a and mir200c expression levels were found to be significantly

decreased in the experimental fatty liver group compared
to the control group. Moreover, there was a significant
difference in the expression levels of these two miRNAs
between the vitamin D3 supplementation group and the
experimental NAFLD group. Moreover, there was no
significant difference between the vitamin D3 and sham
groups in terms of these two miRNA levels (Figures 4a
and 4b).
As a result of the KEGG pathway analysis, miRNAs
(mir-33a, mir-200c) were found to play a common role in
the Hippo signaling pathway, lysine degradation, protein
processing in endoplasmic reticulum, and Wnt signaling
pathway (Table 5) (Figure 5).

Figure 2. Immunohistochemical stainings of different
groups.
Ki-67 (left column) and iNOS (right column)
immunostained sections of Group 1 to 3, from
up to down, respectively. A,B: Barely detectable
immunopositivity; C,D: strong positive expression; E,F:
relatively weak expression. Black arrow indicates positive
expression of immunohistochemical staining. Scale bars
= 20 µm, total magnification 400×.

Figure 3. Histopathological results of study groups (macrovesicular steatosis, microvesicular steatosis,
hepatocellular hypertrophy, inflammation, and Ki-67 and iNOS, respectively).
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Table 4. Immunohistochemistry scoring system of iNOS and Ki-67.
Immunohistochemistry scoring system
● iNOS

● Ki-67

Group 1

Group 2

Group 3

Score

Score

Score

0 (–)

2 (++)

2 (++)

0 (–)

2 (++)

1 (+)

Figure 4. Expression levels of mir-33a (a) and mir-200c (b) among study
groups. NAFLD: Nonalcoholic fatty liver disease ∗p < 0.05.
Table 5. Overrepresented pathways, which could be affected by miR-33a and miR-200c.
# KEGG pathway

p-value

#miRNAs

Hippo signaling pathway

0.012

2

Lysine degradation

0.004

2

Protein processing in endoplasmic reticulum

0.001

2

Wnt signaling pathway

0.013

2

Figure 5. The significant clusters/heat map representation of mir-33a and mir-200c.
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4. Discussion
Consumption of HFCS products has been strictly
integrated to modern western-style diet and excess
exposure to HFCS products are one of the prominent
factors blamed for body fat accumulation, obesity, and
also fatty liver. Clinically acceptable therapeutic agents are
being investigated for this health problem [16]. This fact
was one of the important trigger points for our current
experimental research.
Vitamin D is one of the most investigated topics
nowadays, and the number of studies about vitamin D,
which is in fact a hormone although historically called a
vitamin, will continue increasing. The growing curiosity
and evidence about positive effects of vitamin D3 to chronic
metabolic, cardiovascular, and neoplastic issues have led
to widespread utilization of vitamin D3 supplementation
for the prevention and treatment of numerous disorders
[17, 18].
In one huge metaanalysis, it has been reported that
higher vitamin D3 concentrations were associated with
lower likelihood of cardiovascular disease, lipid disorders,
glucose metabolism disorders, infectious diseases, multiple
sclerosis, mood disorders, and total mortality [19]. Results
of our current study suggest that HFCS increases the
inflammation and leads to fatty liver in animals and vitamin
D3 supplementation may have a protective effect against
this process. In their study, Roth et al. have demonstrated
that vitamin D deficiency, along with a Western-style
eating pattern, results in insulin resistance and NAFLD,
eventually leading to nonalcoholic steatohepatitis (NASH)
(20). However, the authors have provided no data about the
effects of vitamin D3 supplementation in that study [20].
Vitamin D deficiency is common all over the world
and it has been regarded that vitamin D deficiency may
be related with NAFLD [21]. Thus, it can be suggested that
vitamin D supplementation may prevent or reduce fatty
liver development. A few previous studies assessing this
assumption have shown both decreased insulin resistance
and improved inflammatory markers with vitamin D
supplementation [22].
Insulin resistance, diabetes, obesity, and NAFLD are
considered chronic inflammatory situations and there are
numerous studies demonstrating a correlation between
these groups of consequences and TNF-alpha [23, 24].
Moreover, some previous studies have shown that vitamin
D supplementation decreases the TNF-alpha expression or
at least may induce a clinical improvement in inflammation.
For example, Shab-Bidar et al. have found that vitamin D
supplementation resulted in a significant improvement in
TNF-alpha levels in patients with type 2 diabetes [25]. In
contrast, Belenchia et al. have carried out a clinical study
on obese adolescents and have reported that vitamin
D supplementation resulted in no significant decrease

in inflammatory markers despite the decreased insulin
resistance [22]. However, in our current study, decreased
levels of TNF-alpha in vitamin D3 supplementation group
support the hypothetical positive role of vitamin D3 on
hepatic inflammation.
NAFLD is often diagnosed by ultrasonography, which
has low sensitivity and specificity. The definitive diagnosis
of NAFLD is usually made by liver biopsy, which is an
invasive procedure. Due to the limitations of liver biopsy,
need for the use of noninvasive markers has emerged in
recent years [26]. The presence of miRNAs in body fluids
such as serum, plasma, or urine and the fact that they
reflect the physiological or pathological conditions of the
tissue they belong to provide a great advantage in their use
as noninvasive biomarkers [27].
Vitamin D3 affects the expression of ZEB1, ZEB2, and
SNAI1, which are inducers of epithelial-mesenchymal
transition. Relatedly, miR‑200b and miR‑200c target ZEB1
[28]. Feng et al., in their experimental study in 2014,
showed that miR-200c was down-regulated in liver tissues
in a NAFLD model created with a high-fat diet [29]. In our
current study, unlike Feng et al., we examined the changes
in the experimental fatty liver model that we created with
a high fructose corn diet. The results of these two studies
are similar in terms of showing the relationship between
mir-200c and NAFLD. The different and unique aspect
of our current study is exhibiting a significant change in
circulating mir-200c levels in an experimental fatty liver
model. Moreover, vitamin D3 supplementation also affected
these circulating mir-200c levels [29]. The most important
advantage of demonstrating the change in circulating
miRNA expression levels in experimental liver studies is
not to have to reach the liver tissue in an invasive way.
Erhartova et al. suggested that circulating miR-33a
levels may be an indicator of liver steatosis development
and inflammation in patients with liver transplantation
[30]. In addition, mir-33a plays a critical role in the
regulation of fatty acid and cholesterol homeostasis [31].
Moreover, it has been reported that mir-33a is directly
related to insulin resistance [32]. For the above reasons,
in this current study, we examined the expression level
of mir-33a in serum samples in HFCS induced fatty liver
model. Finally, we found that circulating mir-33a levels
were changed significantly with the development of fatty
liver and also with vitamin D3 supplementation [30]. Our
current results suggest that easily available circulating mir33a will be used as a biomarker for the diagnosis of fatty
liver and also disease course.
As an inevitable finding, in this current study, we
showed that liver structure was clearly changed with
HFCS. Microvesicular steatosis and sinusoidal dilatation
occurred and inflammatory cell infiltration took place.
Moreover, it was a very prominent positive finding that
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vitamin D3 supplementation caused less microvesicular
adiposity and hepatocellular hypertrophy in hepatocellular
zone. Previously, Han et al. created a fatty liver model
with a choline-deficient diet and examined the effects
on the liver by applying different doses of vitamin D3
supplementation [33]. Differently, we showed that fatty
liver can easily develop after HFCS application, which is
widely consumed in the community. In addition, for the
first time in the literature, we regarded that vitamin D3related liver changes are associated with miR-33a and mir200c, and circulating expression levels of these miRNAs
may be diagnostic for fatty liver.
In conclusion, our current fatty liver study
demonstrated that vitamin D3 supplementation, especially
in a proper dose, could attenuate adverse inflammatory,
metabolic and hepatic effects of HFCS via miR-33a and
mir-200c. Moreover, at a specified dose and at a limited
time interval, vitamin D3 can diminish HFCS-induced
hepatic lipid accumulation, inflammation, and also fatty
degeneration. Finally circulating miR-33a and mir-200c
may be used as biomarkers for predicting fatty liver and
vitamin D3 supplementation-related hepatic changes.
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